Break Through Cancer today announced its formal launch as a public foundation designed to find new solutions to the most intractable challenges in cancer. The foundation is being launched with an extraordinary challenge pledge of $250 million from Mr. and Mrs. William H. Goodwin, Jr. and their family, and the estate of William Hunter Goodwin III. This represents one of the largest gifts ever in support of cancer research.
The first randomized Phase II clinical trial to report on single and combined neoadjuvant immune checkpoint inhibitor therapy in stage I-III...
The University of Texas MD Anderson Cancer Center and Mirati Therapeutics, Inc. today announced a strategic research and development...
The University of Texas MD Anderson Cancer Center is proud to support World Cancer Day, Feb. 4, to honor the international effort to eliminate the devastating disease.
An initiative of the Union for International Cancer Control (UICC), World Cancer Day has focused on a singular theme, “I Am and I Will,” for the past three years. The multi-year campaign was designed to inspire and empower individuals to take action toward prevention...
Emil J Freireich, M.D., a trailblazing oncologist who developed groundbreaking therapies for childhood leukemia and came to be recognized...